<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: To improve the prognostic evaluation of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> requires new molecular markers </plain></SENT>
<SENT sid="1" pm="."><plain>Cancerous inhibitor of protein phosphatase 2A (CIP2A) serves as an oncoprotein by targeting PP 2A-mediated inhibition of c-Myc </plain></SENT>
<SENT sid="2" pm="."><plain>A prognostic role for CIP2A has been demonstrated in gastric, lung and <z:e sem="disease" ids="C0153349" disease_type="Neoplastic Process" abbrv="">tongue cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: CIP2A was overexpressed in 661 (87.9%) specimens </plain></SENT>
<SENT sid="4" pm="."><plain>CIP2A overexpression was associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> differentiation grade (p = 0.014), p53 immunopositivity (p = 0.042), EGFR immunopositivity (p = 0.007) and c-Myc nuclear immunopositivity (p = 0.018) </plain></SENT>
<SENT sid="5" pm="."><plain>In survival analysis, CIP2A failed to show any prognostic significance (p = 0.270, log-rank test) </plain></SENT>
<SENT sid="6" pm="."><plain>METHODS: 863 consecutive <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients treated at Helsinki University Central Hospital in 1983â€“2001 were collected with 752 scored successfully for CIP2A immunohistochemical expression from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue microarrays </plain></SENT>
<SENT sid="7" pm="."><plain>Associations with clinicopathologic variables and molecular markers were explored by the chi-square test, and the Kaplan-Meier method served for survival analysis </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Overexpression of CIP2A in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients may be an important step in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Based on our findings, CIP2A shows no association with patient prognosis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, but is associated with nuclear c-Myc </plain></SENT>
</text></document>